Literature DB >> 11535962

Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases.

P C Konturek1, S J Konturek, P Pierzchalski, W Bielański, A Duda, K Marlicz, T Starzyńska, E G Hahn.   

Abstract

BACKGROUND: Epidemiological and animal studies demonstrated a link between gastric cancer (GC) or mucosal associated lymphoid tissue (MALT) lymphoma and chronic infection with Helicobacter pylori (H. pylori). The exact mechanism responsible for the development of GC and MALT-lymphoma in H. pylori-infected patients still remains obscure. This report is designed to overview the molecular biology, especially the gene expression and histochemical manifestation of gastrin and other growth factors such as transforming growth factor alpha (TGF alpha) and hepatocyte growth factor (HGF) in the GC before and after eradication of H. pylori. Furthermore, gene expression of cyclooxygenase-1 (COX-1) and COX-2 and apoptosis-related proteins such as Bax and Bcl-2 are discussed.
MATERIAL AND METHODS: The findings originate from two series of patients; Series I involving 337 GC patients and 400 age- and gender-matched controls and series 2 including 20 MALT-lymphoma patients and 40 matched controls.
RESULTS: An overall H.pylori-seropositivity reached about 80% in GC and about 90% in MALT-lymphoma, significantly higher than in non-cancer controls (60%). The prevalence of CagA-positive strains was about twice as high (about 70%) in GC and MALT-lymphomas as in sex- and age-matched controls. Expression of gastrin was detected in antrum of all tested patients but also in majority (90%) of GCs and MALT-lymphomas tumor tissue. HGF and TGF alpha were expressed more frequently in GC tissue than in normal fundic mucosa. COX-1 was similarly expressed in GC and MALT as in intact mucosa, while COX-2 mRNA was detected only in tumor tissue, being attenuated by H.pylori eradication in GC and abolished by this therapy in MALT-lymphoma. The plasma levels of alpha-amidated gastrin in GC and MALT were several folds higher than in controls. Gene expression of bcl-2 was detected in all, while bax--only in about 50% of GC samples.
CONCLUSIONS: Infection with H. pylori, especially that expressing CagA-positivity, is primum movens in developing GC and MALT-lymphoma and the upregulation of growth factors, particularly of gastrin, and COX-2 and dysregulation of the Bax/Bcl-2 system seem to contribute to gastric cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535962

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  10 in total

1.  Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy.

Authors:  Anna Zub-Pokrowiecka; Kazimierz Rembiasz; Peter C Konturek; Andrzej Budzyński; Stanisław J Konturek; Marek Winiarski; Władysław Bielański
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach.

Authors:  Chengzhong Xing; Shunji Kato; Norio Matsukura; Noriko Matsuda; Huimian Xu; En Takashi; Nobutaka Yamada; Zenya Naito; Takashi Tajiri
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Relationship of Helicobacter pylori to Bcl-2 family expression, DNA content, and pathological characteristics of gastric cancer.

Authors:  Mohamed El-Shahat; Samir El-Masry; Mahmoud Lotfy; Ayman El-Meghawry El-Kenawy; Wesam A Nasif
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.

Authors:  Dong-Li Guo; Ming Dong; Lan Wang; Li-Ping Sun; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Expression of survivin and caspase-3 in gastric cancer.

Authors:  J Kania; S J Konturek; K Marlicz; E G Hahn; P C Konturek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

6.  Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ling Li; Bing-Zhong Sun; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

7.  Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma.

Authors:  Hao Zhang; Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang; Hai-Feng Liu; Yuan-Hui Luo
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

8.  Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organism.

Authors:  Trevor A Winter; Mark Kidd; Philip Kaye; I N Solly Marks
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

9.  Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.

Authors:  Peter C Konturek; Stanislaw J Konturek; Wladyslaw Bielanski; J Kania; Monika Zuchowicz; Artur Hartwich; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

10.  Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer.

Authors:  Waldemar Bartchewsky; Mariana R Martini; Aline C Squassoni; Marisa C Alvarez; Marcelo S P Ladeira; Daisy M F Salvatore; Miriam A Trevisan; José Pedrazzoli; Marcelo L Ribeiro
Journal:  Dig Dis Sci       Date:  2009-01-22       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.